Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Active, not recruiting Phase 2 Interventional

Efficacy/Safety of ALTB-268 in Subjects w/Moderately to Severely Active UC Refractory to Biologics

ClinicalTrials.gov ID: NCT06109441

Public ClinicalTrials.gov record NCT06109441. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 24, 2026, 5:33 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Phase 2a, Multicenter, Open-Label Study Evaluating the Efficacy and Safety of ALTB-268 in Subjects With Moderately to Severely Active Ulcerative Colitis Refractory to Biologic Therapy

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

ALTB-268-201 is a Phase 2a, multicenter, single arm, multiple-dose, open-label study evaluating the efficacy and safety of ALTB-268 in subjects with moderately to severely active UC. The study consists of a Screening Phase, an Induction Phase and a LTE (Long Term Extension)

Study identification

NCT ID
NCT06109441
Recruitment status
Active, not recruiting
Study type
Interventional
Phase
Phase 2
Lead sponsor
AltruBio Inc.
Industry
Enrollment
50 participants

Conditions and interventions

Interventions

Biological

Eligibility (public fields only)

Age range
18 Years to 75 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Dec 4, 2023 (Actual)
Primary completion
Mar 5, 2026 (Actual)
Completion
Mar 2028 (Estimated)
Last update posted
May 5, 2026

2023 – 2028

United States locations

U.S. sites
23
U.S. states
13
U.S. cities
23
Facility City State ZIP Site status
San Diego Gastroenterology San Diego California 92103 —
Rocky Mountain Gastroenterology Littleton Colorado 80120 —
Gastro Health Research Miami Florida 33176 —
Digestive and Liver Center of Florida, LLC Orlando Florida 32825 —
Alliance Clinical Research of Tampa, LLC. Tampa Florida 33615 —
Gastro Health Partners Southern Indiana New Albany Indiana 47150 —
Gastro Health Partners Louisville Louisville Kentucky 40218 —
Louisiana Research Center, LLC. Shreveport Louisiana 71105 —
Gastroenterology Associates of North Mississippi Oxford Mississippi 38655 —
New York Presbyterian Hospital - Weill Cornell Medical Colllege New York New York 10065 —
Gastroenterology Group of Rochester Rochester New York 14618 —
Digestive Disease Medicine of Central New York Utica New York 13502 —
Dayton Gastroenterology, LLC Beavercreek Ohio 45440 —
Gastro Health Ohio Liberty Township Ohio 45044 —
Frontier Clinical Research, LLC Uniontown Pennsylvania 15401 —
Gastroenterology Associates, P.A. Greenville South Carolina 29607 —
DHAT / GI Aliance Garland Texas 75044 —
Caprock Gastro Reasearch Lubbock Texas 19424 —
GI Alliance Mansfield Texas 760603 —
Southern Star Research Institute LLC San Antonio Texas 78229 —
Tyler Research Institute Tyler Texas 75701 —
GI Alliance Webster Texas 33016 —
Wisconsin Center for Advanced Research Milwaukee Wisconsin 53215 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 1 non-U.S. site.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT06109441, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted May 5, 2026 · Synced Oct 24, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT06109441 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →